Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25693012

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2015 Feb 19
First author
Swain SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Apr;12(4):188. doi: 10.1038/nrclinonc.2015.40.
    note
    Source null
    related pmid
    25734635
    relationship
    Comment in
  2. citation
    N Engl J Med. 2015 May 14;372(20):1964-5. doi: 10.1056/NEJMc1503446.
    note
    Source null
    related pmid
    25970056
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 May 14;372(20):1964. doi: 10.1056/NEJMc1503446.
    note
    Source null
    related pmid
    25970057
    relationship
    Comment in

Authors and identifiers

  1. name
    Swain SM
    type
    Author
  2. name
    Baselga J
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Ro J
    type
    Author
  5. name
    Semiglazov V
    type
    Author
  6. name
    Campone M
    type
    Author
  7. name
    Ciruelos E
    type
    Author
  8. name
    Ferrero JM
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Heeson S
    type
    Author
  11. name
    Clark E
    type
    Author
  12. name
    Ross G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Swain SM
    type
    Author
  2. name
    Baselga J
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Ro J
    type
    Author
  5. name
    Semiglazov V
    type
    Author
  6. name
    Campone M
    type
    Author
  7. name
    Ciruelos E
    type
    Author
  8. name
    Ferrero JM
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Heeson S
    type
    Author
  11. name
    Clark E
    type
    Author
  12. name
    Ross G
    type
    Author
bibliography ids
  1. nci-bib-428f1a34238924495a83e7e5
book metadata
content sha256
18d89de6ee8c107160418418b1db08a81d2ddfb1a1d39507794cc7e8b77bb1cc
document type
citation
dois
  1. 10.1056/NEJMoa1413513
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:25693012
immutable id
pubmed:25693012@18d89de6ee8c107160418418b1db08a81d2ddfb1a1d39507794cc7e8b77bb1cc
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
724-34
volume
372
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Apr;12(4):188. doi: 10.1038/nrclinonc.2015.40.
    note
    Source null
    related pmid
    25734635
    relationship
    Comment in
  2. citation
    N Engl J Med. 2015 May 14;372(20):1964-5. doi: 10.1056/NEJMc1503446.
    note
    Source null
    related pmid
    25970056
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 May 14;372(20):1964. doi: 10.1056/NEJMc1503446.
    note
    Source null
    related pmid
    25970057
    relationship
    Comment in
outcomes validated
false
pmid
25693012
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
b11fb3423a9e1f2df63e2f376c4977f47218f5356f5c4bced944e98aa1557222
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Feb 19
precision
day
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25693012/
title
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.

Preserved source evidence · Not medical advice